To further characterize the CD44high cells, we compared sorted CD44high/E-selectin+ and CD44low/-/E-selectin- cells for their in vivo leukemia development ability after transplantation at limiting dilution (Supplementary Fig. 15A). The gene discussed is SELE; the disease is leukemia.